Chronic Care Management

Improve outcomes and lower the cost of care for your patients living with diabetes.

Approximately one-third of all people living with diabetes rely on insulin, yet less than half are achieving their A1C goal — the key marker of glucose control. As a result, many struggle with their day-to-day health and well being, causing more visits to doctor’s offices, emergency departments and urgent care centers as well as more hospitalizations.

How does Glytec help?

Glytec combines FDA-cleared technologies with the services of diabetes care management professionals to optimize insulin therapy for your highest risk patients and deliver the results that matter most: rapid attainment of target blood glucose and sustained reduction in A1C.

By markedly improving outcomes, as shown in multiple studies,1-51Use of Decision Support Software to Titrate Multiple Daily Injections Yielded Sustained A1c Reductions After 1 Year. Journal of Diabetes Science and Technology, January 2017.2Blood Glucose Testing Frequency Correlates to A1C Reduction After 3 Months of Insulin Titration Utilizing Glucommander™. International Conference on Advanced Technologies & Treatments for Diabetes, February 2018.3Glucommander™ Outpatient, a Cloud-Based Insulin Management Solution, Titrated Patients to Goal in 11 Days and Sustained a 2.6% Drop in HBA1C Over 6 Months. International Conference on Advanced Technologies & Treatments for Diabetes, February 2017.4Glucommander™ Outpatient, a Cloud-Based Insulin Management Solution Adjusted Insulin Doses and Achieved 2.7% Drop in A1c Percentage Points. American Diabetes Association Scientific Sessions, June 2016.5Use of Decision Support Software to Titrate Multiple Daily Injections Yielded Sustained A1c Reductions After 1 Year. European Association for the Study of Diabetes Annual Meeting, September 2017. Glytec serves as a direct catalyst for potential cost savings, estimated at $2,800 per patient per year for each percentage point reduction in A1C.6-86Enterprise Evaluation and Population Health Analytics. CVS. October 2016 updated November 2017.7Glimer et al. Predictors of health care costs in adults with diabetes. Diabetes Care. 2005 Jan;28(1):59-64.8Fitch K1, Pyenson BS, Iwasaki K. Medical claim cost impact of improved diabetes control for Medicare and commercially insured patients with type 2 diabetes. J Manag Care Pharm. 2013 Oct;19(8):609-20, 620a-620d.

Why does insulin optimization play such an important role?

Everybody responds to insulin differently, and their needs change over time. For insulin to be effective, dose adjustments must be timely, precise and data-driven, and that’s exactly what Glytec accomplishes.

Glytec offers a virtual care program that centers on use of Glucommander™ Outpatient, a pioneering digital therapeutic (software-as-a-medical-device) designed to ensure people with diabetes are taking the right dose of insulin at the right time.
Learn More
 

We remove the barriers to successful insulin use -- a win for patients providers and payers alike. The results are dramatic:1-51Use of Decision Support Software to Titrate Multiple Daily Injections Yielded Sustained A1c Reductions After 1 Year. Journal of Diabetes Science and Technology, January 2017.2Blood Glucose Testing Frequency Correlates to A1C Reduction After 3 Months of Insulin Titration Utilizing Glucommander™. International Conference on Advanced Technologies & Treatments for Diabetes, February 2018.3Glucommander™ Outpatient, a Cloud-Based Insulin Management Solution, Titrated Patients to Goal in 11 Days and Sustained a 2.6% Drop in HBA1C Over 6 Months. International Conference on Advanced Technologies & Treatments for Diabetes, February 2017.4Glucommander™ Outpatient, a Cloud-Based Insulin Management Solution Adjusted Insulin Doses and Achieved 2.7% Drop in A1c Percentage Points. American Diabetes Association Scientific Sessions, June 2016.5Use of Decision Support Software to Titrate Multiple Daily Injections Yielded Sustained A1c Reductions After 1 Year. European Association for the Study of Diabetes Annual Meeting, September 2017.

Number of Days to Target Blood Glucose

6.1 to 11

Percentage-Point Reduction in A1C

2.5 to 3.5

Percent Severe Hypoglycemia <40 mg/dL

0.00 to 0.05

Number of Months A1C Reduction Sustained

12

“Patients whose treatment is guided by Glucommander™ have greater peace of mind, they’re more confident that their insulin therapy is working, and as a result, they’re more engaged. They also get to goal much quicker.”
Joseph Johnson, PA-C
Physician Assistant Specializing in Diabetes Care, Atlanta Diabetes Associates

“We realized within the first two weeks that I needed three times the insulin I was taking. This program is literally a lifesaver."

Jessica
Type 1 Diabetes

“I like the instant feedback and that I don’t have to wait 3 or 4 months until my next doctor’s appointment to have my dose adjusted.”

George
Type 2 Diabetes

“I feel so much better. I no longer have frequent thirst or blurred vision. I am extremely pleased with my progress in this program.”

Sam
Type 2 Diabetes

 
Glytec helps primary care providers overcome the complexities, fears and time-intensive processes associated with initiating and titrating insulin. They’re able to CONFIDENTLY treat more patients and achieve better outcomes.
Learn More

We can tailor a virtual care program to fit your needs.

LET’S TALK